Alloferon-1 trifluoroacetate is primarily used in immunomodulatory and antiviral therapies. It enhances the activity of natural killer (NK) cells and cytotoxic T lymphocytes, which play critical roles in the body’s defense against viral infections and tumor cells. This compound has been investigated for its potential in treating viral diseases such as influenza and herpes due to its ability to induce interferon production and boost innate immune responses. It is also explored in cancer immunotherapy, where it supports immune surveillance by increasing the cytotoxic capacity of immune cells. Due to its stability and bioavailability in trifluoroacetate form, it is suitable for experimental and therapeutic formulations in preclinical research.